BioCryst Reports Third Quarter 2018 Financial Results

Go back to BioCryst Reports Third Quarter 2018 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.99 --0 (-0%)
Previous Close $8.99    52 Week High $10.98 
Open $8.99    52 Week Low $1.63 
Day High $8.99    P/E N/A 
Day Low $8.99    EPS $-0.68 
Volume 36,097